Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 110

1.

An observational clinical study of the efficacy and tolerability of donepezil in the treatment of Alzheimer's disease.

Hager K, Calabrese P, Frölich L, Göbel C, Berger FM.

Dement Geriatr Cogn Disord. 2003;15(4):189-98.

PMID:
12626851
2.

[Early diagnosis and treatment of Alzheimer's disease. Implementation in the doctor's office].

Kohler J, Riepe MW, Jendroska K, Pilartz H, Adler G, Berger FM, Calabrese P, Frölich L, Gertz HJ, Hampel H, Haupt M, Mielke R, Paulus HJ, Zedlick D.

Fortschr Med Orig. 2002 Dec 5;120(4):135-41. German.

PMID:
12613271
3.

[Early diagnosis and therapy of Alzheimer dementia. Careful documentation prevents degeneration].

Kohler J, Riepe MW, Jendroska K, Pilartz H, Adler G, Berger FM, Calabrese P, Frölich L, Gertz HJ, Hampel H, Haupt M, Mielke R, Paulus HJ, Zedlick D.

MMW Fortschr Med. 2002 Nov 21;144(47):53-4. German. No abstract available.

PMID:
12532523
4.

Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease.

Frölich L, Klinger T, Berger FM.

J Neurol Sci. 2002 Nov 15;203-204:137-9.

PMID:
12417372
5.

Aberrant morphology of Müller glial cells in retinas of a microphthalmic mouse strain.

Hilbig H, Brylla E, Berger FM, Reissig D.

J Hirnforsch. 1998;39(2):155-60.

PMID:
10022339
6.

Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilis.

Houba V, Berger FM, Dinarello CA, Johnson AG, Le J, Mauël J, Van der Meer JW, Philippeaux MM, Vilcek J, Vogels MT.

Dev Biol Stand. 1992;77:121-8.

PMID:
1426652
7.

The use of antianxiety drugs.

Berger FM.

Clin Pharmacol Ther. 1981 Mar;29(3):291-4. No abstract available.

PMID:
6110502
8.

Effect of antianxiety drugs on fear and stress.

Berger FM.

Behav Sci. 1980 Jul;25(4):315-21.

PMID:
6106471
9.

Suppressive effects of chlorphenesin on lymphocyte function in mice and humans.

Stites DP, Brecher G, Schmidt L, Berger FM.

Immunopharmacology. 1979 Dec;2(1):39-49.

PMID:
162236
10.

4-(p-Chlorophenylthio)butanol (W-2719), a new non-antihistaminic drug for immediate hypersensitivity allergies.

Fukui GM, Ludwig BJ, Sofia RD, Reisner DB, Berger FM.

Arzneimittelforschung. 1979;29(6):912-7.

PMID:
90512
11.

Ernest Singer.

Berger FM.

Med J Aust. 1977 Jun 4;1(23):863. No abstract available.

PMID:
331036
12.

Commentary: present status of clinical psychopharmacology.

Berger FM.

Clin Pharmacol Ther. 1976 Jun;19(6):725-31. Review. No abstract available.

PMID:
5214
13.

Commentary. Depression and antidepressant drugs.

Berger FM.

Clin Pharmacol Ther. 1975 Sep;18(3):241-8. Review. No abstract available.

PMID:
240528
14.

Enhancement of immunity against murine syngeneic tumors by a fraction extracted from non-pathogenic mycobacteria.

Lamensans A, Chedid L, Lederer E, Rosselet JP, Gustafson RH, Spencer HJ, Ludwig B, Berger FM.

Proc Natl Acad Sci U S A. 1975 Sep;72(9):3656-60.

15.

Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395).

Sofia RD, Diamantis W, Gordon R, Kletzkin M, Berger FM, Edelson J, Singer H, Douglas JF.

Eur J Pharmacol. 1974 Apr;26(1):51-62. No abstract available.

PMID:
4545529
16.

Preparation and biological properties of water-soluble adjuvant fractions from delipidated cells of Mycobacterium smegmatis and Nocardia opaca.

Adam A, Ciorbaru R, Petit JF, Lederer E, Chedid L, Lamensans A, Parant F, Parant M, Rosselet JP, Berger FM.

Infect Immun. 1973 Jun;7(6):855-61.

17.

The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent.

Berger FM, Bates HM, Diamantis W, Kletzkin M, Plekss OJ, Sofia RD, Spencer HJ.

Pharmacology. 1973;9(3):164-76. No abstract available.

PMID:
4714232
18.

Attenuation of certain neoplasias by chlorphenesin. 1.

Spencer HJ, Runser RH, Berger FM, Tarnowski, Mathé G.

Proc Soc Exp Biol Med. 1972 Sep;140(4):1156-61. No abstract available.

PMID:
4341553
19.

Biological study of a nontoxic, water-soluble immunoadjuvant from mycobacterial cell walls.

Chedid L, Parant M, Parant F, Gustafson RH, Berger FM.

Proc Natl Acad Sci U S A. 1972 Apr;69(4):855-8.

20.

Social implications of psychotropic drugs.

Berger FM.

Adv Pharmacol Chemother. 1972;10:105-18. No abstract available.

PMID:
4677610
21.

Studies on the mechanism of protodyne-induced protection against microbial infections.

Berger FM, Fukui GM, Gustafson RH, Rosselet JP.

Proc Soc Exp Biol Med. 1971 Nov;138(2):391-5. No abstract available.

PMID:
4330232
22.

Potential antiinflammatory agents. Aralkoxyhydrouracils and aralkoxyhydantoins.

Simet L, Reisner DB, Ludwig BJ, Dürsch F, Berger FM.

J Med Chem. 1970 Nov;13(6):1067-71. No abstract available.

PMID:
5479842
23.

The effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) on experimental atherosclerosis and hypercholesteremia.

Berger FM, Douglas JF, Ludwig BJ, Margolin S.

J Pharmacol Exp Ther. 1969 Dec;170(2):371-81. No abstract available.

PMID:
4982312
24.

Effect of N-gamma-phenylpropyl-N-benzyloxy acetamide (W-1372) and of clofibrate on the lipids of normal and hypercholesteremic rats.

Berger FM, Douglas JF, Lu GG, Ludwig BJ.

Proc Soc Exp Biol Med. 1969 Oct;132(1):293-7. No abstract available.

PMID:
5344849
25.

Increased host resistance to infection elicited by lipopolysaccharides from Brucella abortus.

Berger FM, Fukui GM, Ludwig BJ, Rosselet JP.

Proc Soc Exp Biol Med. 1969 Sep;131(4):1376-81. No abstract available.

PMID:
4980494
26.

Carbamate derivatives related to meprobamate.

Ludwig BJ, Powell LS, Berger FM.

J Med Chem. 1969 May;12(3):462-72. No abstract available.

PMID:
5788163
27.

The effect of chlorphenesin on the immune response.

Berger FM, Fukui GM, Goldenbaum EG, DeAngelo M, Chandlee GC.

J Immunol. 1969 Apr;102(4):1024-31. No abstract available.

PMID:
4976666
28.

The significance of laboratory studies in the evaluation and discovery of psychoactive agents in man.

Berger FM.

Dis Nerv Syst. 1969 Feb;30(2):Suppl:5-10. No abstract available.

PMID:
4886992
29.

Mental disease and drugs affecting it.

Berger FM.

Perspect Biol Med. 1969 Autumn;13(1):31-44. Review. No abstract available.

PMID:
4900950
30.

Effect of chlorphenesin on localized hemolysis in gel assay.

Fukui GM, Berger FM, Chandlee GC, Goldenbaum EG.

J Bacteriol. 1968 Oct;96(4):1133-6.

31.

Effect of plasma on non-specific resistance to infection induced by endotoxin or protodyne.

Fukui GM, Goldenbaum E, Berger FM.

Nature. 1968 Apr 27;218(5139):362-3. No abstract available.

PMID:
4870184
32.

Increase of nonspecific resistance to infection by protodyne, a protein component derived from bacterial protoplasm.

Berger FM, Fukui GM, Ludwig BJ, Rosselet JP.

Proc Soc Exp Biol Med. 1968 Feb;127(2):556-9. No abstract available.

PMID:
4967029
33.

Computers and medical discoveries.

Berger FM, Kroitor HP.

Perspect Biol Med. 1967 Autumn;11(1):63-70. doi: 10.1353/pbm.1967.0007. No abstract available.

PMID:
25578164
34.

The synthesis of hydroxylamine derivatives prossessing hypocholesteremic activity.

Ludwig BJ, Dürsch F, Auerbach M, Tomeczek K, Berger FM.

J Med Chem. 1967 Jul;10(4):556-64. No abstract available.

PMID:
6037042
35.

The physicians' counselor...a tribute to Harry Beckman.

Berger FM.

Wis Med J. 1967 Jul;66(7):312-3. No abstract available.

PMID:
4859974
36.

Control of the mind.

Berger FM.

Am Sci. 1967 Mar;55(1):67-71. No abstract available.

PMID:
6068649
37.

Drugs and suicide in the United States.

Berger FM.

Clin Pharmacol Ther. 1967 Mar-Apr;8(2):219-23. No abstract available.

PMID:
6021582
38.

Selective suppression of penicillin hypersensitivity by certain phenoxy propanediols.

Berger FM, Fukui G, Ludwig BJ, Margolin S.

Proc Soc Exp Biol Med. 1967 Jan;124(1):303-10. No abstract available.

PMID:
6017786
39.

The effect of endotoxin on resistance to infection and disease.

Berger FM.

Adv Pharmacol. 1967;5:19-46. Review. No abstract available.

PMID:
4864477
40.

Control of the mind.

Berger FM.

Am J Pharm Sci Support Public Health. 1966 Mar-Apr;138(2):51-6. No abstract available.

PMID:
5931982
41.

Major and minor tranquilizers.

Berger FM.

JAMA. 1965 Nov 8;194(6):681-2. No abstract available.

PMID:
5897254
42.

ANXIETY AND ITS TREATMENT.

BERGER FM.

J Am Soc Psychosom Dent Med. 1965 Jul;12:53-64. No abstract available.

PMID:
14333714
43.

The combined action of meprobamate and benactyzine.

Berger FM, Kletzkin M, Margolin S.

Med Pharmacol Exp Int J Exp Med. 1965;13(2):103-16. No abstract available.

PMID:
5897043
44.

SYMPOSIUM ON ANXIETY AND A DECADE OF TRANQUILIZER THERAPY. THE TRANQUILIZER DECADE.

BERGER FM.

J Neuropsychiatr. 1964 Oct;5:403-10. No abstract available.

PMID:
14249406
45.

PHARMACOLOGIC PROPERTIES OF A NEW TRANQUILIZING AGENT, 2-METHYL-2-PROPYLTRIMETHYLENE BUTYLCARBAMATE CARBAMATE (TYBAMATE).

BERGER FM, KLETZKIN M, MARGOLIN S.

Med Exp Int J Exp Med. 1964;10:327-44. No abstract available.

PMID:
14165722
46.

ENDOTOXIN INDUCED RESISTANCE TO INFECTIONS AND TOLERANCE.

BERGER FM, FUKUI GM.

Proc Soc Exp Biol Med. 1963 Dec;114:780-3. No abstract available.

PMID:
14120348
47.

EFFECT OF BENZYL N-BENZYL CARBETHOXYHYDROXAMATE (W-398) ON EXPERIMENTAL ATHEROSCLEROSIS AND HYPERCHOLESTEREMIA.

BERGER FM, DOUGLAS JF, LUDWIG BJ, MARGOLIN S.

Proc Soc Exp Biol Med. 1963 Nov;114:337-41. No abstract available.

PMID:
14101182
48.

The similarities and differences between meprobamate and barbiturates.

BERGER FM.

Clin Pharmacol Ther. 1963 Mar-Apr;4:209-33. No abstract available.

PMID:
13970672
49.

Folic acid activity in Puerto Rican foods.

SANTINI R Jr, BERGER FM, BERDASCO G, SHEEHY TW, AVILES J, DAVILA I.

J Am Diet Assoc. 1962 Dec;41:562-7. No abstract available.

PMID:
13976382
50.

The treatment of anxiety. A critical review.

BERGER FM.

J Neuropsychiatr. 1962 Nov-Dec;4:98-103. No abstract available.

PMID:
13970671

Supplemental Content

Loading ...
Support Center